Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Preferred Stock Liabilities (2016)

Anaptysbio filings provide 1 years of Preferred Stock Liabilities readings, the most recent being $40.7 million for Q4 2016.

  • For the quarter ending Q4 2016, Preferred Stock Liabilities changed N/A year-over-year to $40.7 million, compared with a TTM value of $40.7 million through Dec 2016, changed N/A, and an annual FY2016 reading of $40.7 million, changed N/A over the prior year.
  • Preferred Stock Liabilities hit $40.7 million in Q4 2016 for Anaptysbio.
  • The five-year high for Preferred Stock Liabilities was $40.7 million in Q4 2016, with the low at $40.7 million in Q4 2016.